Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Personalized Medicine|December 16, 2020
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted BiopsiesDaniël F Osses, Christian Arsov, Lars Schimmöller, et al.
EJNMMI Research|March 4, 2022
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body <sup>68</sup> Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?Janna Morawitz, Julian Kirchner, Johannes Hertelendy, et al.
The Journal of Urology|September 25, 2017
Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the ProstateTim Ullrich, Michael Quentin, Christian Arsov, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 17, 2022
Value of T<sub>2</sub> Mapping MRI for Prostate Cancer Detection and ClassificationMaximilian Klingebiel, Lars Schimmöller, Elisabeth Weiland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancerChrista Haldrup, Kamilla Mundbjerg, Else Marie Vestergaard, et al.
European Urology Open Science|February 1, 2024
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS StudyBirte Valentin, Christian Arsov, Tim Ullrich, et al.
European Urology|August 8, 2018
Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk CalculatorsArnout R Alberts, Monique J Roobol, Jan F M Verbeek, et al.
Molecular Oncology|February 25, 2016
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levelsChrista Haldrup, Anne-Sofie Lynnerup, Tine Maj Storebjerg, et al.
International Journal of Cancer|January 25, 2022
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trialChristian Arsov, Peter Albers, Kathleen Herkommer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2014
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomyHelle Kristensen, Christa Haldrup, Siri Strand, et al.
Pageof 6